Search

everythinglearnresearchcommunity

for

Search:↓

Tacrolimus ointment is effective for various skin conditions but needs more research for long-term effects.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Suplatast tosilate successfully treated a woman's systemic sclerosis symptoms.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Canakinumab's effect on COVID-19 outcomes is unclear.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Ruxolitinib can cause a delayed skin reaction on the nose.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Clobetasol is more effective than metformin for treating localized alopecia areata.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Tacrolimus and corticosteroids can improve symptoms of Satoyoshi syndrome.

Switching to generic tacrolimus was safe, effective, and saved money.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

CTP-543 is generally safe for treating alopecia areata.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Mitotane changes steroid breakdown, affecting cortisol availability.